This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 329:5 · Repealed by 2021, 197:78, II, eff. July 1, 2021

329:5 Repealed by 2021, 197:78, II, eff. July 1, 2021. –

Copy link

Related materials

Bill relationships

  • 2026 HB1292 reference · effective 2027-01-01

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1292-FN reference · effective 2027-01-01

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1321 amend

    ravenous therapy. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Provision of Elective Intravenous Therapy. Amend RSA 329 by inserting after section 53 the following new subdivision: Provision of Elective Intravenous Therapy 329:54 Definitions. As used in this subdivision, "elective intravenous therapy" means a procedure: I. To admin

  • 2026 HB1335 amend · effective 2027-01-01

    use of Representatives in General Court convened: 1 New Subdivision; Physicians and Surgeons; Disclosure of Preferential Promotion Received by Provider; When Required. Amend RSA 329 by inserting after section 53 the following new subdivision: Disclosure of Preferential Promotion 329:54 Definitions. In this subdivision: (a) “Preferential promotion” means any financial arrangement, incentiv

  • 2026 HB1376 amend

    factor relevant to determining what is in the best interest of the child, as provided for by law. 7 Limitations on Breast Surgeries for Minors; Exceptions to Prohibition. Amend RSA 329:53, II(d) and (e) to read as follows: (d) The procedure is needed to correct gynecomastia and symptomatic macromastia; [or] (e) Treatment of congenital deformities of the breast and/or chest wall[.]; or (f) At the

  • 2026 HB1702 reference

    the area where customers are provided prescription medications via a drive-through window. 329:56 Enforcement. I. A health care provider or pharmacy that knowingly violates RSA 329:55 shall be guilty of a class B felony. II. Any woman prescribed, dispensed, or administered a drug intending to induce a chemical abortion without being informed by the notice outlined under RSA 329:55 may, in a civil a

  • 2026 HB1702 amend

    seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or

  • 2026 HB1702-FN reference

    the area where customers are provided prescription medications via a drive-through window. 329:56 Enforcement. I. A health care provider or pharmacy that knowingly violates RSA 329:55 shall be guilty of a class B felony. II. Any woman prescribed, dispensed, or administered a drug intending to induce a chemical abortion without being informed by the notice outlined under RSA 329:55 may, in a civil a

  • 2026 HB1702-FN amend

    seeking chemical abortions that it may be possible to undo the effects of mifepristone, a drug commonly used to induce abortions. 2 New Subdivision; Chemical Abortion. Amend RSA 329 by inserting after section 53 the following new subdivision: Chemical Abortion 329:54 Definitions. In this subdivision: I. "Chemical abortion" or "medical abortion" means the use or prescription of any drug or

  • 2026 HB1735 reference

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1735-FN reference

    withstanding any provision of law to the contrary, the board of medicine shall not revoke, fail to renew, or take any other action against a physician's license issued pursuant to RSA 329 based primarily on a physician's recommendation to [an eligible] a patient regarding or prescription for or treatment with [an investigational] a drug, biologic, or device pursuant to this chapter. II. Notwithstandi

  • 2026 HB1769 reference · effective 2027-01-01

    rred patients for abortions shall, as a condition of receiving any contract, grant, or other public funds from a public body, submit an affidavit stating its intent to comply with RSA 329:50-b, I. The public body shall retain the affidavit for not less than 2 years. The affidavit shall be signed under oath by an authorized agent of the recipient organization. 329:50-c Penalties. I. Any contract made